A retrospective analysis of dabrafenib and/or dabrafenib plus trametinib combination in patients with metastatic melanoma to characterize patients with long-term benefit in the individual patient program (Describe iii)

Victoria G. Atkinson, Pietro Quaglino, Massimo Aglietta, Michele Del Vecchio, Roberta Depenni, Francesca Consoli, Dimitrios Bafaloukos, Pier Francesco Ferrucci, Skaiste Tulyte, Ivana Krajsová, Paolo A. Ascierto, Rossana Gueli, Ana Arance, Helen Gogas, Hiya Banerjee, Teddy Saliba, Egbert de Jong, Bart Neyns

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A retrospective analysis of dabrafenib and/or dabrafenib plus trametinib combination in patients with metastatic melanoma to characterize patients with long-term benefit in the individual patient program (Describe iii)'. Together they form a unique fingerprint.

Medicine & Life Sciences